Yang DL, Ye L, Zeng FJ, Liu J, et al. Erratum: Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in Hepatology 2025 Jun 25. doi: 10.1097/HEP.0000000000001401.
PMID: 40560675